Pharmaceutical companies to promote the production and sales of Chinese herbal pieces
Release time:
2022-12-13
walked into the traditional Chinese medicine decoction pieces workshop of Jinhua pharmaceutical company. the air was full of strong flavor of traditional Chinese medicine. the cooking machine "poop-poop " in the cooking room was steaming. the staff in charge of the care came to check the production situation from time to time. In the washing room, the machinery and equipment have just been cleaned, waiting for the next batch of medicinal materials "patronage " , several employees cooperate with tacit understanding, skillfully put Chinese herbal medicine into packaging bags, weighing, sealing, packing and storing in the warehouse, waiting to be shipped to the market ...... This is the production of Chinese herbal medicine workshop normal.
In the past two years, the sales volume and production orders of Chinese herbal pieces of pharmaceutical companies have increased significantly. In order to ensure that all orders of Chinese herbal pieces can be completed with good quality and quantity, the front-line production workers are working at full capacity and working overtime to put into production. Due to space constraints, the Chinese herbal medicine workshop arranges up to three different varieties of Chinese medicine production at a time, interspersed with processing procedures such as cleaning, slicing, drying, sterilization, packaging and storage. The weekly business department of the workshop receives orders for production and scheduling. The production volume of 16-20 tons of Chinese herbal pieces should be completed in one month, reaching 90 tons in one month at most. The production workshop is busy with production. When the business and storage personnel are tight, the pharmaceutical company also organizes logistics personnel to help ensure the on-time delivery of orders.
"The implementation of the new policy of no more than 25% of Chinese herbal pieces has not only reduced the medical expenses of patients, effectively guided the masses to choose more Chinese medicine services, but also promoted the concept of high quality and good price of Chinese herbal pieces. Wu Weisheng, general manager of " Pharmaceutical Company, said that on the 28th of June 1# this year, the "Implementation Opinions of Zhejiang Medical Security Bureau on Supporting the Inheritance and Innovation of Traditional Chinese Medicine" was formally implemented. Zhejiang Province required public medical institutions to strictly implement the bonus policy of increasing 25% sales according to the actual purchase price. The prices of Chinese herbal pieces in many places have dropped significantly, medical institutions pay more attention to the quality of drugs when purchasing Chinese herbal pieces. With the help of this policy change, pharmaceutical companies further optimize the suppliers of raw medicinal materials and purchase raw materials on the premise of high quality and good price. Every process in the production process is very strict. In addition to the on-site follow-up by the quality inspection personnel, each batch of traditional Chinese medicine produced is sent to the quality inspection center for inspection to ensure the quality of each batch of medicinal materials and give full play to the curative effect of medicinal materials. so that people can use conscience medicine, rest assured medicine and fine medicine anytime and anywhere. The high quality of products naturally drives the increase of sales volume. The output of Chinese herbal medicine workshop has also increased significantly compared with the same period last year, and the market development has also reached a new high. This year, the pharmaceutical company successfully broke through from
14suppliers of traditional Chinese medicine and became one of 2 suppliers of Jinhua Hospital of Traditional Chinese Medicine. The sales volume directly doubled from the original small proportion. 4# Starting in 39, the bid for the distribution right of Chinese herbal pieces of medical institutions in Pan 'an County was won. , distribution bidding for township hospitals in Wucheng District, the pharmaceutical company ranked first in the distribution enterprise in terms of qualification, service and sample quality. The sales volume of Chinese herbal pieces in a hospital in Yongkang has also doubled this year. The relevant person in charge of the Chinese medicine department of the pharmaceutical company said that the increase in production capacity and sales, with sales, not only ensures product quality, but also reduces procurement costs to a certain extent, forming a healthy development of production and sales. Wu Weisheng said that at present, the traditional Chinese medicine decoction pieces business of pharmaceutical companies includes production and trade, with both self-operated varieties and OEM products. Next, pharmaceutical companies will also give full play to their advantages, adjust the industrial structure, and make every effort to promote the production and sales of Chinese herbal pieces according to the actual production of enterprises.
(ReporterNi Yingzhen)
More information
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-22
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-30
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page